A two‐stage trial design for testing treatment, self‐selection and treatment preference effects
- 1 April 1989
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 8 (4) , 477-485
- https://doi.org/10.1002/sim.4780080411
Abstract
We propose a two-stage randomized clinical trial design for separating treatment effects from those resulting from choosing treatment. At the first stage all patients are randomly allocated to one of two groups, the random group and the option group. At the second stage, patients in the random group are randomized a second time to treatment A or B, whereas patients in the option group are given a free choice between the two treatments. If there are differences in treatment response between the random group and the option group, there are two potential sources of bias: self-selection by choosing treatment, and effects of suggestion by receiving the preferred treatment. A linear model is presented to estimate these effects separately along with test statistics which are approximately normally distributed.Keywords
This publication has 15 references indexed in Scilit:
- The combination of randomized and historical controls in clinical trialsPublished by Elsevier ,2004
- Binary Data in Prerandomized DesignsBiometrical Journal, 1989
- Selection bias and randomized consent designsJournal of Chronic Diseases, 1986
- Informed consentBMJ, 1986
- Does informed consent influence therapeutic outcome? A clinical trial of the hypnotic activity of placebo in patients admitted to hospital.BMJ, 1986
- ResponseJournal of Chronic Diseases, 1986
- Validity and treatment dilution in zelen's single consent designStatistics in Medicine, 1984
- Efficacy of Tonsillectomy for Recurrent Throat Infection in Severely Affected ChildrenNew England Journal of Medicine, 1984
- The Relative Efficiency of Zelen's Prerandomization Design for Clinical TrialsPublished by JSTOR ,1983
- A New Design for Randomized Clinical TrialsNew England Journal of Medicine, 1979